Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Finasteride reduces some inflammation in BPH but not all.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

A vitamin D receptor mutation causes rickets and affects immune responses.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Targeting regulatory T cells may help treat age-related diseases.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Blocking IL-17a can improve age-related smell loss in mice.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

New treatments for seborrheic dermatitis show promise for difficult cases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Dupilumab users have a higher risk of developing alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.